Mustapha Bittaye

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa et al. · Cell · 2021 · 1.2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai et al. · Cell · 2021 · 749 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Antibody evasion by the P.1 strain of SARS-CoV-2

Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa et al. · Cell · 2021 · 661 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17